Biotech Investors & VC Firms
2475 firms in this list, with a median first check of $500K. 505 of them lead rounds. Generated from verified public data and updated continuously.
Threshold Impact
KelownaSeed
1 person
Trans-it Capital
Palo AltoSeed
1 person
Bioverge
San FranciscoSeed
6 people
Halls Investments
Bryanston
Hub Angels
BostonSeed–Series A
Kakawa Investment Management
LagosSeed
Pura Vida Investments
New YorkLate Stage
Regeneron Ventures
Seed
Vamare Investments Group
Athens
BDC Life Sciences Venture Fund
MontrealSeed–Series A
2 people
Magellan Technology Investment
SeoulSeed–Series A
2 people
Next Sequence
2 people
EQx Fund
BostonPre-Seed–Series A
1 person
First Venture
StockholmSeed–Growth
1 person
HaloHealth
TorontoPre-Seed–Seed
1 person
Japan Science and Technology Agency
TokyoPre-Seed–Growth
1 person
Lanchi Ventures
SingaporePre-Seed–Series A
1 person
Neuhauss Capital UG
HamburgPre-Seed
1 person
Venbridge
TorontoSeed–Late Stage
1 person
Zedcrest Capital
LagosPre-Seed–Seed
1 person
Comway Capital Ltd.
ShanghaiSeed–Series B
Olive Capital
AthertonSeed
Paris-Saclay Seed Fund
SaclaySeed$2.5M
Shinsei Capital Partners
TokyoPre-Seed–Late Stage
Related lists
Investors & VC Firms in North America (12835)Investors & VC Firms in United States (11883)Investors & VC Firms in Europe (5830)Investors & VC Firms in Global (4736)AI & Machine Learning Investors & VC Firms (4564)Fintech Investors & VC Firms (4546)SaaS Investors & VC Firms (4222)Healthtech Investors & VC Firms (4190)Enterprise Software Investors & VC Firms (4099)Crypto & Web3 Investors & VC Firms (3974)
Data sourced from public filings and firms' own websites — see our methodology.















